D. Ackermann

Founder at

Presidio Medical, Inc.

44 year

10 connections

Health Technology

Consumer Services

Commercial Services

Profile

Dr. D.
M.
Ackermann is an Advisor at Vensana Capital Management LLC, a Chief Executive Officer, CFO & Secretary at Osanni Bio, Inc. and a Director-Biotechnology at Stanford Byers Center for Biodesign.
He is on the Board of Directors at Presidio Medical, Inc. Dr. Ackermann was previously employed as a Chairman by Tarsus Pharmaceuticals, Inc., a Vice President-Neurostimulation by Allergan, Inc., a Chairman by Oyster Point Pharma, Inc., a President & Chief Executive Officer by Oculeve, Inc., and a Co-Founder by Tangible Science, Inc. He received his undergraduate degree from Vanderbilt University, a graduate degree from Case Western Reserve University and a doctorate degree from Case Western Reserve University.

D. Ackermann active positions

Companies	Position	Start
Presidio Medical, Inc. Presidio Medical, Inc. Medical SpecialtiesHealth Technology Develops neuromodulation platform to establish a class of therapeutic medical devices	Founder	01/01/2017
Stanford Byers Center for Biodesign Stanford Byers Center for Biodesign Miscellaneous Commercial ServicesCommercial Services Engages in training of health technology innovators	Corporate Officer/Principal	-
Vensana Capital Management LLC Vensana Capital Management LLC Investment ManagersFinance Vensana Capital invests in companies located across the globe, primarily in the United States. The firm focuses on companies operating in the field medical technology sector such as medical devices, life science tools & diagnostics, and data science & tech-enabled solutions. It provides financing for early and growth stage capital requirements with an investment size of USD 15 - 50 million.	Consultant / Advisor	01/10/2019

All active positions of D. Ackermann

Former positions of D. Ackermann

Companies	Position	End
TARSUS PHARMACEUTICALS, INC.	Founder	02/12/2022
OYSR POIN	Founder	08/10/2020
ALLERGAN, INC.	Corporate Officer/Principal	01/06/2017
Oculeve, Inc. Oculeve, Inc. Medical SpecialtiesHealth Technology Develops devices for dry eye disease treatment	Chief Executive Officer	11/08/2015
Tangible Science, Inc. Tangible Science, Inc. Medical SpecialtiesHealth Technology Develops a novel polymer based coating technology for use in contact lenses to treat dry eye disease	Founder	-

See the detail of D. Ackermann's experience

Training of D. Ackermann

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of D. Ackermann's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Allergan, Inc. Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Oculeve, Inc. Oculeve, Inc. Medical SpecialtiesHealth Technology Develops devices for dry eye disease treatment	Health Technology
Vanderbilt University Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Case Western Reserve University Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tangible Science, Inc. Tangible Science, Inc. Medical SpecialtiesHealth Technology Develops a novel polymer based coating technology for use in contact lenses to treat dry eye disease	Health Technology
Oyster Point Pharma, Inc. Oyster Point Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops and commercializes pharmaceutical therapies to treat ocular surface diseases	Commercial Services
Vensana Capital Management LLC Vensana Capital Management LLC Investment ManagersFinance Vensana Capital invests in companies located across the globe, primarily in the United States. The firm focuses on companies operating in the field medical technology sector such as medical devices, life science tools & diagnostics, and data science & tech-enabled solutions. It provides financing for early and growth stage capital requirements with an investment size of USD 15 - 50 million.	Finance
Tarsus Pharmaceuticals, Inc. Tarsus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapeutic drugs for blepharitis	Health Technology
Presidio Medical, Inc. Presidio Medical, Inc. Medical SpecialtiesHealth Technology Develops neuromodulation platform to establish a class of therapeutic medical devices	Health Technology
Stanford Byers Center for Biodesign Stanford Byers Center for Biodesign Miscellaneous Commercial ServicesCommercial Services Engages in training of health technology innovators	Commercial Services